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Background:  Mehran’s risk score was developed for simple prediction of contrast-induced nephropathy (CIN) after percutaneous coronary 
intervention (PCI). We investigated whether Mehran’s risk score can predict long-term outcomes of AMI patients.
Methods:  We analyzed clinical data from 1041 consecutive AMI patients treated by PCI from May 2005 to July 2009. CIN was defined as an 
increase in serum creatinine (>25% or >0.5 mg/dL) within 2 days after PCI. Primary endpoint was the rate of major adverse cardiorenal events, a 
composite of death, reinfarction, target-vessel revascularization, heart failure requiring hospitalization, cerebrovascular events, and renal failure 
requiring dialysis.
Results:  Patients were categorized into 4 risk groups: relatively low (n = 596 [57%]), moderate (n = 265 [25%]), high (n = 111 [11%]), and very 
high (n = 69 [7%]), corresponding to risk scores of ≤5, 6 to 10, 11 to 15, and ≥16, respectively. CIN was observed in 148 patients (relatively low 53 
[9%], moderate 31 [12%], high 39 [35%], very high 25 [36%]). Patients in higher risk group had higher rates of major adverse cardiorenal events 
(relatively low 13%, moderate 20%, high 28%, very high 45%, p<0.001) and mortality (relatively low 3%, moderate 10%, high 24%, very high 38%, 
p<0.001) at 2 years. However, Mehran’s score could not predict the reversibility of impaired renal function after development of CIN.
Conclusion: Mehran`s risk score was able to predict CIN and long-term clinical outcomes in patients with AMI undergoing PCI. 
